Evidence map›Paper›PMID 42726159›Full record

ReviewCardiovascular toxicology2026

Ferroptosis-Mitochondrial Crosstalk in Cardiomyocyte Death: The Cardiomyocyte Ferroptotic Amplification Circuit (CFAC) as a Proposed, Testable Systems Framework.

Abiya Ahad, Darshan Hullon

Abstract readReview
PubMed Publisher
In one paragraph

Review in Cardiovascular toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Abiya AhadAnanta Institute of Medical Sciences and Research Centre, Rajsamand, Rajasthan, India. ahadabiya15@gmail.com.ORCID 0009-0008-5767-0722
Darshan HullonMercyOne Clinton Medical Centre, Clinton, IA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiomyocyte loss in heart failure is conventionally attributed to apoptosis and necrosis, yet neither fully accounts for the metabolic signature, irreversibility, or magnitude of cell loss in ischemia-reperfusion injury, diabetic cardiomyopathy, or pressure-overload failure. Ferroptosis and mitochondrial dysfunction each contribute to cardiac injury, but their mechanistic interdependence has not been formally modeled. We propose, explicitly as a hypothesis-generating model rather than an established mechanism, the Cardiomyocyte Ferroptotic Amplification Circuit (CFAC), in which ferroptosis and mitochondrial dysfunction are reciprocally reinforcing rather than parallel. CFAC comprises three interlocked positive-feedback loops: an inorganic loop (mitochondrial iron → Fenton ROS → Fe-S cluster disassembly → labile iron); an organic loop (mitochondrial ROS → PE-PUFA peroxidation → electron transport chain adduction → ROS); and a proposed proteotoxic loop (phospholipid hydroperoxide accumulation → hypothesized GPX4 inactivation by electrophilic lipid-peroxidation products → further peroxide accumulation). We postulate that cyclophilin D-regulated permeability transition marks a terminal tipping point at which loss of membrane potential and matrix glutathione extinguishes residual GPX4 activity. The model predicts that partial suppression of two or more loops may outperform complete blockade of one loop, and defines a candidate CFAC-active cardiac phenotype, which requires prospective validation and is proposed neither as a diagnostic entity nor as a distinct cardiomyopathy. Individual components are supported by published experimental work; their integration into a single coupled, nonlinear, threshold-dependent circuit is our inference and is presently unproven. Bistability in the strict sense (two stable states with a hysteretic return path) is a proposed property of that circuit that has not been demonstrated in any system; the framework is therefore described throughout as a proposed nonlinear threshold model, and the experiment that would test bistability directly is specified in Sect. 8.5. The framework is accordingly stated as three nested claims of decreasing security, namely a coupled and threshold-dependent circuit, a bistable and hysteretic extension of it, and a translational phenotype hypothesis, each with its own prespecified falsification criterion, so that a negative result identifies which claim it has ended (Sect. 8.1). We therefore present CFAC as a falsifiable framework and specify the experiments that would confirm or refute it.

Indexed as

FerroptosisHeart FailureIronMitochondria, HeartModels, CardiovascularMyocytes, CardiacAnimalsCell DeathFeedback, PhysiologicalHumansLipid PeroxidationOxidative StressPhospholipid Hydroperoxide Glutathione PeroxidaseReactive Oxygen SpeciesSignal TransductionIronPhospholipid Hydroperoxide Glutathione PeroxidaseReactive Oxygen SpeciesCardiomyocyte deathCFACFerroptosisGPX4Heart failureHypothesis-generating frameworkIronLipid peroxidationMitochondriaNonlinear threshold dynamics

Identifiers

PMID42726159

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.